Essential Equipment Taskforce Resource CenterResources to assist Illinois companies to rapidly accelerate the productive capacity to manufacture and source personal protective equipment
Essential Equipment Taskforce
The Essential Equipment Taskforce is a public and private sector partnership to help companies bridge significant gaps in the healthcare manufacturing supply-chain and directly provide personal protective equipment and other supplies to the Illinois’ front-line healthcare workers so they can treat patients safely and efficiently.
Here is how you can help us rapidly increase the supply of personal protective equipment to support the healthcare workers on the front lines combating the COVID-19 pandemic.
I'm a service provider who would like to donate my time to help companies respond to the COVID crisis
I'm a manufacturer/supplier or distributor & can respond to the COVID crisis
There are over 20 critical supplies needed to respond to COVID-19. If your company currently does or can quickly begin production, please fill out this form.
I'm a manufacturer looking for a supplier or distributor
The IMEC resource center can help connect you to the partners you need.
I need to connect to relevant life sciences supplies, capacities, and resources
BIO’s Coronavirus Hub connects life sciences companies that have relevant supplies, capacities, and resources to share, with those companies, researchers, or healthcare providers that need them.
I have medical equipment I would like to donate
iBIO is coordinateng equipment donations from our community and sending them to the Illinois Emergency Management Agency (IEMA)
FDA Guidance Documents & Announcements:
In response to growing difficulties companies are expecting to face running trials, the Food and Drug Administration has issued a new guidance to help navigate the problems. Considerations for ongoing trials: Ensuring the safety of trial participants is paramount....
Coronavirus (COVID-19) Update: FDA Provides More Regulatory Relief During Outbreak, Continues to Help Expedite Availability of Diagnostics
Today, as part of our ongoing and aggressive commitment to address the coronavirus outbreak, the FDA updated a policy originally issued on Feb. 29 on diagnostic testing for coronavirus (COVID-19) in order to achieve more rapid testing capacity in the U.S. We believe...